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Yoichiro Kato1*, Susumu Konari2, Wataru Obara1, Tamotsu Sugai3 and Tomoaki Fujioka1Abstract
Background: Villous adenoma arising in the urinary tract is rare tumor. Most cases have been identified as benign
neoplasm in the colon. Villous adenoma of the gastrointestinal tract is thought arise from premalignant polyps.
Here, we report a case of concurrence of villous adenoma and non-muscle invasive bladder cancer.
Case presentation: An 85-year-old woman presented at our office because of gross hematuria. Cystoscopic
examination detected two papillary tumors in the bladder. Each tumor was resected and diagnosed, respectively.
Histopathology confirmed that the resected one tumor was a villous adenoma, and the other was urothelial
carcinoma (T1, high grade). Immunostaining for cytokeratin (CK) 7, CK20 and Ki-67 confirmed that CK7: (−), CK20:
(+) and Ki-67: (<=30%) in villous adenoma while CK7: (+), CK20: (+), and Ki-67: (70%) in urothelial carcinoma.
Three months later from TUR, urothelial carcinoma recurred in the trigone. She received adjuvant intravesical
immunotherapy with BCG post TUR for the recurrence site.
Conclusion: There were no specific findings on ultrasonography, CT, MRI or cystoscopic examination
morphologically. Therefore, pre-pathological villous adenoma of the bladder is extremely difficult to diagnose. There
are some case reports of solitary villous adenoma in the bladder or with coexisting adeno carcinoma. However, to
the best of our knowledge, this is only the second report of villous adenoma in the bladder of coexisting urothelial
carcinoma that has been published in the literature. Premalignant villous adenoma of the bladder is extremely rare
and difficult to diagnose without histologic examination. Any suspicious lesion of the bladder should be biopsied
and/or resected to confirm histology.
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Villous adenoma first reported by Norbury LE in 1928 [1]
is now recognized as a premalignant polyp of the gastro-
intestinal tract. Up to two-thirds of the lesion occurs in the
rectum. There are no differences in distribution between
men and women and a peak incidence in the 60’s and 70’s
[2]. Whenever possible, local excision and sphincter preser-
vation is the procedure of choice for accessible lesions with
favorable characteristics. However, the recurrence is seen in
up to 40% of cases even despite complete excision in the
rectal [3].* Correspondence: j2c789@bma.biglobe.ne.jp
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reproduction in any medium, provided the orOn the other hand, the villous adenoma in the urinary
tract is rare. The most common coexisting tumor is
adenocarcinoma which is associated with urachus tumors
[4]. Typical clinical presentations are hematuria and irrita-
tive symptoms [5]. The prognosis of pure villous adenoma
in the urinary tract is excellent.Case presentation
An 85-year-old woman with no significant past medical
history, including colon cancer but urethral caruncle two
years ago presented at our office because of painless gross
hematuria.
Physical examination showed no remarkable findings.
Laboratory abnormalities were no pyuria but microscopic
hematuria and mild anemia.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mass, 15 mm in diameter, on the right bladder wall. Sub-
sequent cystoscopic examination detected two papillary
tumors in the bladder. This confirmed that the bigger
one was same size as that on US on the right upper wall
with a peduncle. The second was 9 mm with some mi-
cro satellite tumors on the left wall. Both of them were
typical papillary tumors morphologically (Figure 1A, B).
An enhanced computed tomographic (CT) scan of the
bladder showed two masses. Larger one measuring
16 mm was in the right wall and the other was 9 mm
mass in the left bladder wall, with enhancement. More-
over, no other masses or no enlarged lymph nodes were
seen except for the bladder.
On magnetic resonance imaging (MRI), T2-weighted
images revealed a solid, low intensity mass measuring
15 mm and the mass could be limited to the right blad-
der wall without muscle invasion. No urachal remnant
was confirmed in a sagittal section. For the 9 mm mass,
MRI revealed that it was limited to the left bladder wall
and was also without muscle invasion.
At this point, we could diagnose multiple non-muscle
invasive bladder cancer. Cold punch biopsy was performed
at cystoscopic examination. We performed a biopsy only
in the right side tumor. The histology confirmed it to
be a villous adenoma. According to this result, a colonos-
copy examination was then performed and no neoplastic
lesion was found. TUR was performed after preoperativeFigure 1 Cystscopy findings and HE histopathologic findings and rep
CK20 and Ki-67. A and a, Villous adenoma: The papillary tumor with pedu
tumor in the left wall in this case the columnar epitherium of tumor was loexaminations. Each tumor was resected and diagnosed,
respectively.
Histopathology confirmed that the resected tumor on the
right wall was a villous adenoma, and the left one was
urothelial carcinoma (T1, high grade). Histologically, the
former consisted of tall columnar epithelium which formed
a villous pattern with vessels and stroma consisting of hypo
connective tissues, few nuclear atypia, and few mitotic
figures. The urothelial tumor consisted predominantly of
papillary growth which formed the structure of the gland
(Figure 1a, b). Immunostaining for cytokeratin (CK) 7,
CK20 and Ki-67 confirmed that in villous adenoma, for
CK20 the staining was positive, Ki-67 was less than 30%,
while CK7 was negative. In distinct contrast, there was very
strong positive staining for both cytokeratins moreover, the
staining for Ki-67 was quite strong at approximately 70% in
urothelial carcinoma.
These findings supported a diagnosis of villous adenoma
and urothelial carcinoma arising in the bladder. On first
follow up on the cystoscopic examination, which was held
3 months later, small papillary tumors were found in the
trigone. Based on this finding, TUR was performed for the
recurring lesion. The recurring tumor was diagnosed as
urothelial carcinoma pathologically. She received adjuvant
intravesical immunotherapy with BCG. After BCG
therapy, she has been followed by cystoscopic examination
for every three months. At the last follow-up, 24 months
after surgery, no local recurrences were detected.resentative immunohistochemical findings for cytokeratin (CK) 7,
ncle was in the right wall. B and b, Urothelial carcinoma: The papillary
nger than that of the villous adenoma. 1, HE. 2, CK7. 3, CK20. 4, Ki-67.
Table 1 Summary of villous adenoma of the urinary tract
with and without other types carcinoma




Cheng et al. [5] 15 8
Seibel et al. [24] 6 9 2 1
Our case 1
Total 34 24 2 2
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The clinical manifestations included gross hematuria, but
none led to an increased suspicion of villous adenoma.
There were no specific findings on ultrasonography, CT,
MRI or cystoscopic examination morphologically. There-
fore, pre-pathological villous adenoma of the bladder is
extremely difficult to diagnose.
We have summarized several isolated case reports and
two case series of villous adenoma with and without other
types of carcinoma in Table 1 [5-24]. Our case in which
the villous adenoma coexists with urothelial carcinoma is
the second case report in the table.
Moreover, clinical features of published reports according
to the types of concurrence carcinomas are presented in
Table 2 [5-24]. Though there are some variabilities of fine-
ness, this table shows us some differences and similarities
between solitary villous adenoma and concurrence villous
adenoma and adenocarcinoma. The other types including
our case are too small number of cases to compare. Age,
gender, predominant symptoms and locations are similar
between solitary villous adenoma and concurrence villous
adenoma and adenocarcinoma. On the other hand, treat-
ments and recurrence and progression rate are differences
between groups. Though, the cases of concurrence villous
adenoma and adenocarcinoma were received more radical









VA (34) (23–88 /61.5) (19/14)**
1. Hematuria (32.4)
2. Irritative symptom (17.6)
3. Unknown (17.6)
VA + AD (24) (31–94 /65.5) (14/10)
1. Hematuria (33.3)
2. Irritative symptom (29.2)
3. Abdminal pain (8.3)
VA + AD + UC (2) (76–92 /84) (2/0) 1. Unknown (100)
VA + UC (2) (66–85 /75.5) (1/1) 1. Hematuria (50.0)
*Including overlap feautures (some indexes > =100%). **No description about sex inrecurrence or progress were higher than solitary villous
adenomas. These outcomes would be attributed to the
malignant grade of adenocarcinoma.
There is no certain reason why the glandular lesion was
in the urinary tract. However, in the 5th fetal month the
end of Wolffian duct opens into the cloaca which is cavity
of area around the anus. By the end of 7th fetal month,
the cloaca is divided by the urorectal septum into a dorsal
rectum and a ventral urogenital sinus. The villous aden-
oma could originate from the rest of cloacal epithelium
[4,6]. Moreover, there were three case reports of villous
adenoma arising after colocystoplasty [25]. That is glandu-
lar lesions coming from urine invasion would be one of
the factors to generate neoplasms.
In the present case, there were clear differences in the
histological findings between the villous adenoma and
the urothelial carcinoma as indicated in the ‘Case report’
(Figure 1a, b).
Immunohistochemical studies demonstrated diagnostic
features indicating positive staining for CK20 but negative
for CK7 and focally positive for Ki-67 in villous adenoma.
In contrast, there was strong positive staining for CK20,
CK7 and very positive staining for Ki-67 in urothelial car-
cinoma in TUR resected tissues. Typically, the patterns of
staining of urothelial tissue are positive for the both CK20
and CK7. In our case of immunohistochemical studies,
both patterns of staining for villous adenoma and urothelial
carcinoma were typical compared with past reports [5]. Ki-
67 is associated with the growth fraction of a given human
cell subset [26]. In Zarineh et al.’s case report of recurrent
villous adenoma, the Ki-67 intensity was 20% [23]. The
staining intensity of Ki-67 corresponded well with our
result (<=30%). In contrast, the pattern of staining of
urothelial carcinoma in our case was more than 70% posi-
tive for Ki-67. Bertz S et al. reported that Ki-67 and CK20
could be potential prognostic markers improving the risk






progress rate % (n)
1. Bladder dome (26.5) 1. TUR (32.4)
2.9%: (1/34 cases)2. Bladder (20.6) 2. Unknown (20.6)
3. Posterior wall (8.8) 3. None (17.6)
1. Bladder (37.5) 1. TUR (29.2)
20.8%: (5/24 cases)2. Urethra (33.3) 2. Total cystectomy (20.8)
3. Bladder dome (16.7) 3. Partial cystectomy (16.7)
1. Bladder (100) 1. TUR (100) 0%: (0/2 cases)
1. Bladder (33.3) 1. Partial cystectomy (50.0)
100%: (2/2 cases)1. Urachus (33.3)
1. TUR (50.0)
1. Lateral wall (33.3)
one case report. ***No description about symptoms in one case series.
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surgery suggesting that a high expression of Ki-67 and
CK20 may be associated with recurrence.
In this case, it was difficult to reveal the relationships
between villous adenoma and urothelial carcinoma,
because of the very small number of case reports. It is a
distinct possibility that the two types of tumors could be
incidental comorbid pathologies.
In the urinary tract, Powell et al. suggested that one
case of villous adenoma progressed to villous adenocar-
cinoma [21]. No progressive cases of isolated villous
adenomas have been found except for Powell’s report.
Cheng et al. suggested that patients with isolated villous
adenoma have an excellent prognosis on condition that
complete resection is performed. However, the case with
coexisting adenocarcinoma may have a good possibility
of experiencing recurrence or distant metastasis, which
will then require more aggressive treatments. Thus it is
very important for us to avoid missing the presence of
carcinomas which may coexist with villous adenoma and
to follow up any malignant changes even in the isolated
villous adenoma case. The number of current reports is
insufficient to enable a valid prognosis.
Conclusions
It was very difficult for us to distinguish between villous
adenoma and urothelial carcinoma on ultrasonography,
CT, MRI or cystoscopic examination. Therefore, pre-
pathological villous adenoma of the bladder is extremely
difficult to diagnose. Though, some case series of villous
adenomas in the bladder were reported [5,24], this is only
the second report of villous adenoma in the bladder of
coexisting urothelial carcinoma that has been published in
the literature. The most important point of this case is to
avoid missing the presence of carcinomas which may co-
exist with villous adenoma and to follow up any malignant
changes even in the isolated villous adenoma case.
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